title: The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants.
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Ayalew
authors.initials: A
authors.lastname: Tefferi
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Terra L
authors.initials: TL
authors.lastname: Lasho
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Alexander
authors.initials: A
authors.lastname: Tischer
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Emnet A
authors.initials: EA
authors.lastname: Wassie
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Christy M
authors.initials: CM
authors.lastname: Finke
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Alem A
authors.initials: AA
authors.lastname: Belachew
authors.affiliation: Division of Cytogenetics, Mayo Clinic, Rochester, MN.
authors.forename: Rhett P
authors.initials: RP
authors.lastname: Ketterling
authors.affiliation: Division of Hematopathology, Mayo Clinic, Rochester, MN.
authors.forename: Curtis A
authors.initials: CA
authors.lastname: Hanson
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN.
authors.forename: Animesh D
authors.initials: AD
authors.lastname: Pardanani
mesh_terms: D037282:Calreticulin / Q000737:chemistry / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation / Q000235:genetics*; D055728:Primary Myelofibrosis / Q000235:genetics*; D011379:Prognosis; D017433:Protein Structure, Secondary; D016019:Survival Analysis
chemical_list: D037282:Calreticulin; D053614:Janus Kinase 2